Merck Kgaa ADR (MKKGY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,014,731 | 2,327,853 | 1,405,354 | 758,904 | 3,067,238 |
| Depreciation Amortization | 2,309,201 | 1,740,667 | 1,221,205 | 492,908 | 2,034,724 |
| Accounts receivable | 85,486 | -105,562 | -187,381 | -69,485 | -8,658 |
| Accounts payable and accrued liabilities | -192,614 | -212,223 | -105,536 | -78,170 | -46,539 |
| Other Working Capital | -335,451 | -369,466 | -562,142 | -112,913 | -765,186 |
| Other Operating Activity | 81,158 | 307,888 | 270,302 | 132,455 | -186,156 |
| Operating Cash Flow | $4,962,511 | $3,689,158 | $2,041,802 | $1,123,699 | $4,095,423 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,812,518 | -1,384,396 | -885,212 | -555,878 | -1,935,152 |
| Net Acquisitions | -837,545 | -609,178 | N/A | N/A | -12,988 |
| Purchase Of Investment | -2,435,807 | -2,016,666 | N/A | -94,456 | -581,195 |
| Sale Of Investment | N/A | 1,753,862 | N/A | 376,738 | 551,973 |
| Purchase Sale Intangibles | -502,094 | -409,051 | -296,148 | -262,739 | -86,584 |
| Other Investing Activity | 1,785,465 | -401,355 | 110,921 | -474,451 | -70,350 |
| Investing Cash Flow | $-3,300,405 | $-2,657,733 | $-774,291 | $-748,047 | $-2,047,712 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,025,552 | 751,027 | 764,599 | N/A | 561,714 |
| Debt Repayment | -2,968,200 | 678,453 | -951,980 | -59,714 | -1,176,460 |
| Dividend Paid | -1,125,384 | -322,183 | -315,532 | -56,456 | -1,259,797 |
| Other Financing Activity | 2,163 | -820,302 | 0 | 0 | -1 |
| Financing Cash Flow | $-1,065,869 | $286,996 | $-502,912 | $-116,170 | $-1,874,544 |
| Exchange Rate Effect | -17,314 | -20,892 | -7,538 | -2,171 | -33,551 |
| Beginning Cash Position | 2,144,722 | 2,179,407 | 2,134,416 | 2,151,857 | 2,006,584 |
| End Cash Position | 2,723,646 | 3,475,836 | 2,891,477 | 2,410,254 | 2,145,119 |
| Net Cash Flow | $578,924 | $1,296,428 | $757,061 | $258,397 | $138,534 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,962,511 | 3,689,158 | 2,041,802 | 1,123,699 | 4,095,423 |
| Capital Expenditure | -1,841,734 | -1,422,882 | -903,519 | -567,821 | -1,955,716 |
| Free Cash Flow | 3,120,777 | 2,266,276 | 1,138,283 | 555,878 | 2,139,707 |